+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 3
Age: 18Years +
All Genders
ID05369052

Evaluation of Contezolid Acefosamil and Contezolid Compared to Linezolid for Adults With Moderate or Severe Diabetic Foot Infections Administered Intravenously and Orally

Led by MicuRx · Updated on 2026-10-13

865

Participants Needed

14

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are evaluating the safety and effectiveness of contezolid acefosamil given intravenously and contezolid taken orally compared to linezolid administered both intravenously and orally in adults with moderate or severe diabetic foot infections DFI. This Phase 3, multicenter, randomized, double-blind study includes about 865 participants who have DFIs suspected or confirmed to be caused by Gram-positive bacteria. The study aims to better understand treatment options for these infections in people with diabetes. Participants will receive either contezolid acefosamilcontezolid or linezolid for 14 to 28 days, totaling 28 to 56 doses. Both treatments are administered intravenously at first and then orally. The study compares these two antibiotic regimens to assess their safety and clinical response in treating moderate to severe diabetic foot infections. During the study, participants will be monitored for the resolution of infection signs and symptoms and whether additional therapy is needed. Assessments include clinical response evaluations at multiple time points, monitoring of adverse events, blood tests like complete blood count, and vital signs such as heart rate. The treatment period lasts up to 28 days, with follow-up of clinical and safety outcomes up to 35 days after the end of therapy.

CONDITIONS

Brief Title

Safety and Efficacy Study of Contezolid Acefosamil and Contezolid Compared to Linezolid Administered Intravenously and Orally to Adults With Moderate or Severe Diabetic Foot Infections (DFI)

Research Team

C

Clinical coordinator

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here